Annual EBITDA
$29.05B$4.04B+16.16%
Summary
- Current Value
- As of today, ABBV annual EBITDA is $29.05B, up +16.16% on
- Historical Performance
- ABBV annual EBITDA is down -6.49% over the past 3 years, up +31.45% over the past 5 years
- All-Time High Comparison
- ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on
- 3-Year Low Comparison
- ABBV annual EBITDA is +16.16% above its 3-year low of $25.01B reached on
- Sector Comparison
- ABBV annual EBITDA is higher than 99.74% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $29.05B | +16.2% | -6.5% | +31.4% | +358.2% | |
| Quarterly EBITDA | $6.96B | +15.3% | -11.9% | +5.8% | +467.8% | |
| TTM EBITDA | $29.19B | +12.5% | -8.1% | +24.2% | +2281.3% | |
| Price | $210.39 | +15.8% | +43.5% | +80.7% | – | |
| PE Ratio | 103.48 | +33.6% | +199.8% | +151.7% | – | |
| Annual Revenue | $61.16B | +8.6% | +5.3% | +33.5% | +291.1% | |
| Annual EPS | $2.36 | -1.2% | -64.4% | -13.3% | -10.7% | |
| Annual EBIT | $21.21B | +27.6% | -6.1% | +35.7% | +311.4% | |
| Annual Net Income | $4.19B | -1.3% | -64.4% | -8.1% | +0.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $31.07B | N/A | -6.5% |
| 5Y | $31.07B | -6.5% | |
| All | $31.07B | -6.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $25.01B | +16.2% | |
| 5Y | $22.10B | N/A | +31.4% |
| All | $5.84B | +397.4% |
EBITDA History
FAQ
What is the current annual EBITDA of ABBV?
As of today, ABBV annual EBITDA is $29.05B
What is 1-year change in ABBV annual EBITDA?
ABBV annual EBITDA is up +16.16% year-over-year
What is 3-year change in ABBV annual EBITDA?
ABBV annual EBITDA is down -6.49% over the past 3 years
How far is ABBV annual EBITDA from its all-time high?
ABBV annual EBITDA is currently -6.49% below its historical high of $31.07B set on December 31, 2022
How does ABBV annual EBITDA rank versus sector peers?
ABBV annual EBITDA is higher than 99.74% of companies in Healthcare sector
When is ABBV next annual earnings release?
As of today, the next annual earnings release for ABBV has not been scheduled
Quarterly EBITDA
$6.96B$714.00M-9.30%
Summary
- Current Value
- As of today, ABBV quarterly EBITDA is $6.96B, down -9.30% on
- Historical Performance
- ABBV quarterly EBITDA is up +15.32% year-over-year, down -11.89% over the past 3 years
- All-Time High Comparison
- ABBV quarterly EBITDA is currently -15.56% below its historical high of $8.24B set on
- 3-Year Low Comparison
- ABBV quarterly EBITDA is +37.49% above its 3-year low of $5.06B reached on
- Sector Comparison
- ABBV quarterly EBITDA is higher than 99.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $6.96B | -9.3% | +15.3% | -11.9% | +5.8% | |
| Annual EBITDA | $29.05B | – | +16.2% | -6.5% | +31.4% | |
| TTM EBITDA | $29.19B | +3.3% | +12.5% | -8.1% | +24.2% | |
| Price | $210.39 | -9.1% | +15.8% | +43.5% | +80.7% | |
| PE Ratio | 103.48 | +5.5% | +33.6% | +199.8% | +151.7% | |
| Quarterly Revenue | $15.00B | -9.7% | +12.4% | +22.7% | +15.3% | |
| Quarterly EPS | $0.39 | -61.5% | -45.6% | +205.1% | -80.3% | |
| Quarterly EBIT | $4.73B | -16.8% | +18.4% | -18.0% | +8.5% | |
| Quarterly Net Income | $701.00M | -61.2% | -45.2% | +204.8% | -80.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.89B | -11.7% | |
| 3Y | $7.90B | N/A | -11.9% |
| 5Y | $8.24B | -15.6% | |
| All | $8.24B | -15.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.04B | N/A | +15.3% |
| 3Y | $5.06B | +37.5% | |
| 5Y | $5.06B | +37.5% | |
| All | $381.85M | +1723.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ABBV?
As of today, ABBV quarterly EBITDA is $6.96B
What is ABBV quarterly EBITDA most recent change?
ABBV quarterly EBITDA was down -9.30% on March 31, 2026
What is 1-year change in ABBV quarterly EBITDA?
ABBV quarterly EBITDA is up +15.32% year-over-year
How far is ABBV quarterly EBITDA from its all-time high?
ABBV quarterly EBITDA is currently -15.56% below its historical high of $8.24B set on December 31, 2022
How does ABBV quarterly EBITDA rank versus sector peers?
ABBV quarterly EBITDA is higher than 99.62% of companies in Healthcare sector
When is ABBV next earnings release?
The next earnings release for ABBV is on
TTM EBITDA
$29.19B$925.00M+3.27%
Summary
- Current Value
- As of today, ABBV TTM EBITDA is $29.19B, up +3.27% on
- Historical Performance
- ABBV TTM EBITDA is up +12.53% year-over-year, down -8.11% over the past 3 years
- All-Time High Comparison
- ABBV TTM EBITDA is currently -8.11% below its historical high of $31.77B set on
- 3-Year Low Comparison
- ABBV TTM EBITDA is +16.92% above its 3-year low of $24.97B reached on
- Sector Comparison
- ABBV TTM EBITDA is higher than 99.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $29.19B | +3.3% | +12.5% | -8.1% | +24.2% | |
| Annual EBITDA | $29.05B | – | +16.2% | -6.5% | +31.4% | |
| Quarterly EBITDA | $6.96B | -9.3% | +15.3% | -11.9% | +5.8% | |
| Price | $210.39 | -9.1% | +15.8% | +43.5% | +80.7% | |
| PE Ratio | 103.48 | +5.5% | +33.6% | +199.8% | +151.7% | |
| TTM Revenue | $62.82B | +2.7% | +9.5% | +10.7% | +25.1% | |
| TTM EPS | $2.03 | -13.9% | -13.3% | -52.1% | -28.2% | |
| TTM EBIT | $20.80B | +3.7% | +18.0% | -10.7% | +35.1% | |
| TTM Net Income | $3.62B | -13.8% | -13.2% | -52.1% | -29.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $29.19B | at high | |
| 3Y | $31.77B | N/A | -8.1% |
| 5Y | $31.77B | -8.1% | |
| All | $31.77B | -8.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $25.94B | N/A | +12.5% |
| 3Y | $24.97B | +16.9% | |
| 5Y | $23.50B | N/A | +24.2% |
| All | $1.23B | +2281.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ABBV?
As of today, ABBV TTM EBITDA is $29.19B
What is ABBV TTM EBITDA most recent change?
ABBV TTM EBITDA was up +3.27% on March 31, 2026
What is 1-year change in ABBV TTM EBITDA?
ABBV TTM EBITDA is up +12.53% year-over-year
How far is ABBV TTM EBITDA from its all-time high?
ABBV TTM EBITDA is currently -8.11% below its historical high of $31.77B set on March 31, 2023
How does ABBV TTM EBITDA rank versus sector peers?
ABBV TTM EBITDA is higher than 99.81% of companies in Healthcare sector
When is ABBV next earnings release?
The next earnings release for ABBV is on
EBITDA Formula
Data Sources & References
- ABBV Official Website www.abbvie.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
- ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
- ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv